Feng, Pf., Liu, Lm. & Shen, Yy. Effect of shenmai Injection on SIL-2R NK and LAK cells of patients with advanced carcinoma., CJIM 1, 255–257 (1995). https://doi.org/10.1007/BF02940690
Feng Pei-fang, Liu Lu-ming, Shen Yu-ying. Effect of shenmai Injection on SIL-2R NK and LAK cells of patients with advanced carcinoma. [J]. Chinese Journal of Integrative Medicine 1(4):255-257(1995)
Feng, Pf., Liu, Lm. & Shen, Yy. Effect of shenmai Injection on SIL-2R NK and LAK cells of patients with advanced carcinoma., CJIM 1, 255–257 (1995). https://doi.org/10.1007/BF02940690DOI:
Feng Pei-fang, Liu Lu-ming, Shen Yu-ying. Effect of shenmai Injection on SIL-2R NK and LAK cells of patients with advanced carcinoma. [J]. Chinese Journal of Integrative Medicine 1(4):255-257(1995) DOI: 10.1007/BF02940690.
Effect of shenmai Injection on SIL-2R NK and LAK cells of patients with advanced carcinoma
摘要
Serum interleukin-2 receptor (sIL-2R) level
activities of natural killer cell (NK) and lymphokine activated killer (LAK) cells were determined in 60 patients with advanced carcinoma (AC) before and after treatment with Shenmai Injection (SMI)
forty healthy persons were taken as non-carcinoma control (NC). The results showed that: Serum sIL-2R level in AC were much higher than those in NC (P<0.05) and activities of NK and LAK cells in AC were much lower than those in NC (P<0.05) before treatment. There was no significant difference among gastric
colonic and lung cancer (P>0.05). After treatment with SMI
it was found that the level of sIL-2R in all patients were obviously lowered (P<0.05) while the activities of NK and LAK cells were signifficantly higher than that prior the treatment (P<0.05). Relevancy was not found between sIL-2R and NK
LAK cells. These data suggested that the immune function was compromised in AC
and SMI has a wide effect of immuno-regulation.
Abstract
Serum interleukin-2 receptor (sIL-2R) level
activities of natural killer cell (NK) and lymphokine activated killer (LAK) cells were determined in 60 patients with advanced carcinoma (AC) before and after treatment with Shenmai Injection (SMI)
forty healthy persons were taken as non-carcinoma control (NC). The results showed that: Serum sIL-2R level in AC were much higher than those in NC (P<0.05) and activities of NK and LAK cells in AC were much lower than those in NC (P<0.05) before treatment. There was no significant difference among gastric
colonic and lung cancer (P>0.05). After treatment with SMI
it was found that the level of sIL-2R in all patients were obviously lowered (P<0.05) while the activities of NK and LAK cells were signifficantly higher than that prior the treatment (P<0.05). Relevancy was not found between sIL-2R and NK
LAK cells. These data suggested that the immune function was compromised in AC
Araden L, Production of hybridoma growth factor by human monocytes. EurJ Immunol 1987;17:141.
Philips JH, Lanier II. Dissection of the lymphokine activated killer phenomenon relative contribution of peripheral blood natural killer cells and T-lymphocytes to cytolysis. J Exp Med 1986;164:814.
Laurence A. The soluble IL-2 receptor biology, function and clinical application. Annals of Internal Medicine 1990;113:619.
Nelson DL. Soluble IL-2R: analysis in normal individuals and in certain disease state. Fed Proc 1987;45:377.
Mrino P. Increased levels of sIL-2R in serum of patients with lung cancer. B J Cancer 1990;61(3):434.
Clinical observation on the treatment of atrial fibrillation with amiodarone combined with Shenmai Injection (参麦注射液)
Shenmai Injection (参麦注射液) inhibiting the extracellular signal regulated kinase-induced human airway smooth muscle proliferation in asthma
Effect of Shenmai Injection (参麦注射液) on ventricular diastolic function in patients with chronic heart failure: An assessment by tissue Doppler imaging
Reperfusion therapy in integrative medicine: the most basic treatment for preventing ventricular remodeling in post-myocardial infarction patients
Effect of Kang’ ai Injection (康艾注射液) on serum level of soluble interleukin-2 receptor and vascular endothelial growth factor in patients with esophageal carcinoma during radiotherapy
Related Author
No data
Related Institution
Emergency Medicine Department, Integrated Chinese and Western Medicine Hospital, Zhejiang University of Traditional Chinese Medicine
Department of Respiratory Diseases, Henan Province People’s Hospital
Department of Internal Medicine, The Second People’s Hospital of Yuhang District
. for Research on the Theory of Qi-Blood of Integrated Medicine, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing